Evaluation of microRNAs as potential biomarkers in circulating HPV-DNA-positive non-small cell lung cancer patients

References

• Xu S, Ma H, Bo Y, Shao M. The oncogenic role of CB2 in the progression of non-small-cell lung cancer. Biomed Pharmacother. 2019;117:109080. doi:10.1016/j.biopha.2019.109080.
   PubMed Web of Science ®Google Scholar
• Xiong WM, Xu QP, Li X, Xiao RD, Cai L, He F. The association between human papillomavirus infection and lung cancer: a system review and meta-analysis. Oncotarget. 2017;8(56):96419–96432. doi:10.18632/oncotarget.21682.
   PubMedGoogle Scholar
• Clément-Duchêne C, Stock S, Xu X, Chang ET, Gomez SL, West DW, Wakelee HA, Gould MK. Survival among never-smokers with lung cancer in the cancer care outcomes research and surveillance study. Ann Am Thorac Soc. 2016;13(1):58–66. doi:10.1513/AnnalsATS.201504-241OC.
   PubMed Web of Science ®Google Scholar
• de Freitas AC, Gurgel AP, de Lima EG, de França São Marcos B, Do Amaral CM. Human papillomavirus and lung cancinogenesis: an overview. J Cancer Res Clin Oncol. 2016;142(12):2415–2427. doi:10.1007/s00432-016-2197-1.
   PubMed Web of Science ®Google Scholar
• Yuan S, Qiu Y, Xu Y, Wang H. Human papillomavirus infection and female infertility: a systematic review and meta-analysis. Reprod Biomed Online. 2020;40(2):229–237. doi:10.1016/j.rbmo.2019.10.019.
   PubMed Web of Science ®Google Scholar
• Zhang R, Chen L, Cui YD, Li G. The association between human papillomavirus infection and smoking, age, gender in lung cancer patients: a meta-analysis. Iran J Public Health. 2019;48(1):1–8.
   PubMed Web of Science ®Google Scholar
• Salman NA, Davies G, Majidy F, Shakir F, Akinrinade H, Perumal D, Ashrafi GH. Association of high risk human papillomavirus and breast cancer: a UK based study. Sci Rep. 2017;7:43591. doi:10.1038/srep43591.
   PubMed Web of Science ®Google Scholar
• Coppock JD, Lee JH. mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer. World J Otorhinolaryngol Head Neck Surg. 2016;2(2):76–83. doi:10.1016/j.wjorl.2016.05.010.
   PubMedGoogle Scholar
• Jensen KK, Grønhøj C, Jensen DH, von Buchwald C. Circulating human papillomavirus DNA as a surveillance tool in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Clin Otolaryngol. 2018;43(5):1242–1249. doi:10.1111/coa.13136.
   PubMed Web of Science ®Google Scholar
• Pornthanakasem W, Shotelersuk K, Termrungruanglert W, Voravud N, Niruthisard S, Mutirangura A. Human papillomavirus DNA in plasma of patients with cervical cancer. BMC Cancer. 2001;1:2. doi:10.1186/1471-2407-1-2.
   PubMed Web of Science ®Google Scholar
• Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM, Zhang GZ. Biological functions of microRNAs: a review. J Physiol Biochem. 2011;67(1):129–139. doi:10.1007/s13105-010-0050-6.
   PubMed Web of Science ®Google Scholar
• Santos JMO, Gil da Costa RM, Medeiros R. Dysregulation of cellular microRNAs by human oncogenic viruses - implications for tumorigenesis. Biochim Biophys Acta Gene Regul Mech. 2018;1861(2):95–105. doi:10.1016/j.bbagrm.2018.01.017.
   PubMed Web of Science ®Google Scholar
• Zheng ZM, Wang X. Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta. 2011;1809(11–12):668–677. doi:10.1016/j.bbagrm.2011.05.005.
   PubMed Web of Science ®Google Scholar
• Lu J, Han B. Liquid biopsy promotes non-small cell lung cancer precision therapy. Technol Cancer Res Treat. 2018;17:1533033818801809. doi:10.1177/1533033818801809.
   Web of Science ®Google Scholar
• Paiva I, Gil da Costa RM, Ribeiro J, Sousa H, Bastos MM, Faustino-Rocha A, Lopes C, Oliveira PA, Medeiros R. MicroRNA-21 expression and susceptibility to HPV-induced carcinogenesis - role of microenvironment in K14-HPV16 mice model. Life Sci. 2015;128:8–14. doi:10.1016/j.lfs.2015.02.020.
   PubMed Web of Science ®Google Scholar
• Araújo R, Santos JMO, Fernandes M, Dias F, Sousa H, Ribeiro J, Bastos MMSM, Oliveira PA, Carmo D, Casaca F, et al. Expression profile of microRNA-146a along HPV-induced multistep carcinogenesis: a study in HPV16 transgenic mice. J Cancer Res Clin Oncol. 2018;144(2):241–248. doi:10.1007/s00432-017-2549-5.
   PubMed Web of Science ®Google Scholar
• Syrjänen KJ. Condylomatous changes in neoplastic bronchial epithelium. Report of a case. Respiration. 1979;38(5):299–304. doi:10.1159/000194095.
   PubMed Web of Science ®Google Scholar
• Shikova E, Ivanova Z, Alexandrova D, Shindov M, Lekov A. Human papillomavirus prevalence in lung carcinomas in Bulgaria. Microbiol Immunol. 2017;61(10):427–432. doi:10.1111/1348-0421.12535.
   PubMed Web of Science ®Google Scholar
• Silva EM, Mariano VS, Pastrez PRA, Pinto MC, Nunes EM, Sichero L, Villa LL, Scapulatempo-Neto C, Syrjanen KJ, Longatto-Filho A. Human papillomavirus is notassociated to non-small cell lung cancer: data from a prospective cross-sectional study. Infect Agents Cancer. 2019;14:18. doi:10.1186/s13027-019-0235-8.
   PubMed Web of Science ®Google Scholar
• Ferreira LL, Biasoli ÉR, Bernabé DG, Nunes CM, Miyahara GI. Plasma HPV DNA is detectable in oral leukoplakia patients. Pathol Res Pract. 2017;213(7):759–765. doi:10.1016/j.prp.2017.04.005.
   PubMed Web of Science ®Google Scholar
• Chiou HL, Wu MF, Liaw YC, Cheng YW, Wong RH, Chen CY, Lee H. The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer. 2003;97(6):1558–1563. doi:10.1002/cncr.11191.
   PubMed Web of Science ®Google Scholar
• Wu L, Wang J, Zhu D, Zhang S, Zhou X, Zhu W, Zhu J, He X. Circulating epstein-barr virus microRNA profile reveals novel biomarker for nasopharyngeal carcinoma diagnosis. Cancer Biomark. 2020;27(3):365–375. doi:10.3233/CBM-190160.
   PubMed Web of Science ®Google Scholar
• Zhang QH, Sun HM, Zheng RZ, Li YC, Zhang Q, Cheng P, Tang ZH, Huang F. Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues. Gene. 2013;527(1):26–32. doi:10.1016/j.gene.2013.06.006.
   PubMed Web of Science ®Google Scholar
• Zhu W, Zhou K, Zha Y, Chen D, He J, Ma H, Liu X, Le H, Zhang Y. Diagnostic value of serum miR-182, miR-183, miR-210, and miR-126 levels in patients with early-stage non-small cell lung cancer. PLoS One. 2016;11(4):e0153046. doi:10.1371/journal.pone.0153046.
   PubMed Web of Science ®Google Scholar
• Zhu W, Liu X, He J, Chen D, Hunag Y, Zhang YK. Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study. BMC Cancer. 2011;11:393. doi:10.1186/1471-2407-11-393.
   PubMed Web of Science ®Google Scholar
• Lin Q, Mao W, Shu Y, Lin F, Liu S, Shen H, Gao W, Li S, Shen D. A cluster of specified microRNAs in peripheral blood as biomarkers for metastatic non-small-cell lung cancer by stem-loop RT-PCR. J Cancer Res Clin Oncol. 2012;138(1):85–93. doi:10.1007/s00432-011-1068-z.
   PubMed Web of Science ®Google Scholar
• Tang T, Wong HK, Gu W, Yu MY, To KF, Wang CC, Wong YF, Cheung TH, Chung TK, Choy KW. MicroRNA-182 plays an onco-miRNA role in cervical cancer. Gynecol Oncol. 2013;129(1):199–208. doi:10.1016/j.ygyno.2012.12.043.
   PubMed Web of Science ®Google Scholar
• Chen J, Deng Y, Ao L, Song Y, Xu Y, Wang CC, Choy KW, Tony Chung KH, Du Q, Sui Y, et al. The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer. Cancer Lett. 2019;460:75–85. doi:10.1016/j.canlet.2019.06.015.
   PubMed Web of Science ®Google Scholar
• Huang X, Le QT, Giaccia AJ. MiR-210–micromanager of the hypoxia pathway. Trends Mol Med. 2010;16(5):230–237. doi:10.1016/j.molmed.2010.03.004.
   PubMed Web of Science ®Google Scholar
• Eilertsen M, Andersen S, Al-Saad S, Richardsen E, Stenvold H, Hald SM, Al-Shibli K, Donnem T, Busund LT, Bremnes RM. Positive prognostic impact of miR-210 in non-small cell lung cancer. Lung Cancer. 2014;83(2):272–278. doi:10.1016/j.lungcan.2013.11.005.
   PubMed Web of Science ®Google Scholar
• Roa WH, Kim JO, Razzak R, Du H, Guo L, Singh R, Gazala S, Ghosh S, Wong E, Joy AA, et al. Sputum microRNA profiling: a novel approach for the early detection of non-small cell lung cancer. Clin Invest Med. 2012;35(5):E271. doi:10.25011/cim.v35i5.18700.
   PubMed Web of Science ®Google Scholar
• He RQ, Cen WL, Cen JM, Cen WN, Li JY, Li MW, Gan TQ, Hu XH, Chen G. Clinical significance of miR-210 and its prospective signaling pathways in non-small cell lung cancer: evidence from gene expression omnibus and the cancer genome atlas data mining with 2763 samples and validation via real-time quantitative PCR. Cell Physiol Biochem. 2018;46(3):925–952. doi:10.1159/000488823.
   PubMedGoogle Scholar
• Nilsen A, Jonsson M, Aarnes EK, Kristensen GB, Lyng H. Reference microRNAs for RT-qPCR assays in cervical cancer patients and their application to studies of HPV16 and hypoxia biomarkers. Transl Oncol. 2019;12(3):576–584. doi:10.1016/j.tranon.2018.12.010.
   PubMed Web of Science ®Google Scholar
• Namløs HM, Meza-Zepeda LA, Barøy T, Østensen IH, Kresse SH, Kuijjer ML, Serra M, Bürger H, Cleton-Jansen AM, Myklebost O. Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One. 2012;7(10):e48086. doi:10.1371/journal.pone.0048086.
   PubMed Web of Science ®Google Scholar
• Huang Y, Ni R, Wang J, Liu Y. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Biomed Pharmacother. 2019;109:1851–1859. doi:10.1016/j.biopha.2018.09.151.
   PubMed Web of Science ®Google Scholar
• Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Lung Cancer. 2013;81(3):388–396. doi:10.1016/j.lungcan.2013.05.007.
   PubMed Web of Science ®Google Scholar
• Chen G, Yu L, Dong H, Liu Z, Sun Y. MiR-182 enhances radioresistance in non-small cell lung cancer cells by regulating FOXO3. Clin Exp Pharmacol Physiol. 2019;46(2):137–143. doi:10.1111/1440-1681.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang H, Li Y, Zhao C, Fan Y, Liu J, Li X, Liu H, Chen J. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene. Mol Carcinog. 2018;57(1):125–136. doi:10.1002/mc.22741.
   PubMed Web of Science ®Google Scholar
• Zhang L, Quan H, Wang S, Li X, Che X. MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition. Tumour Biol. 2015;36(10):8121–8126. doi:10.1007/s13277-015-3550-8.
   PubMedGoogle Scholar
• Zhu C, Deng X, Wu J, Zhang J, Yang H, Fu S, Zhang Y, Han Y, Zou Y, Chen Z, et al. MicroRNA-183 promotes migration and invasion of CD133(+)/CD326(+) lung adenocarcinoma initiating cells via PTPN4 inhibition. Tumour Biol. 2016;37(8):11289–11297. doi:10.1007/s13277-016-4955-8.
   PubMedGoogle Scholar
• Zha W, Cao L, Shen Y, Huang M. Roles of Mir-144-ZFX pathway in growth regulation of non-small-cell lung cancer. PLoS One. 2013;8(9):e74175. doi:10.1371/journal.pone.0074175.
   PubMed Web of Science ®Google Scholar
• Gao F, Wang T, Zhang Z, Wang R, Guo Y, Liu J. Regulation of activating protein-4-associated metastases of non-small cell lung cancer cells by miR-144. Tumour Biol. 2015. doi:10.1007/s13277-015-3866-4.
   Google Scholar
• Liu Q, Ma L, Jones T, Palomero L, Pujana MA, Martinez-Ruiz H, Ha PK, Murnane J, Cuartas I, Seoane J, et al. Subjugation of TGF β signaling by human papilloma virus in head and neck squamous cell carcinoma shifts DNA repair from homologous recombination to alternative end joining. Clin Cancer Res. 2018;24(23):6001–6014. doi:10.1158/1078-0432.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Huang Y, Liu M, Yan Q, Zhao W, Yang P, Gao Q, Wei J, Zhao W, Ma L. Epigallocatechin gallate inhibits cell growth and regulates miRNA expression in cervical carcinoma cell lines infected with different high-risk human papillomavirus subtypes. Exp Ther Med. 2019;17(3):1742–1748. doi:10.3892/etm.2018.7131.
   PubMed Web of Science ®Google Scholar
• Xu L, Yang BF, Ai J. MicroRNA transport: a new way in cell communication. J Cell Physiol. 2013;228(8):1713–1719. doi:10.1002/jcp.24344.
   PubMed Web of Science ®Google Scholar
• Chen X, Liang H, Zhang J, Zen K, Zhang CY. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol. 2012;22(3):125–132. doi:10.1016/j.tcb.2011.12.001.
   PubMed Web of Science ®Google Scholar
• Qu H, Xu W, Huang Y, Yang S. Circulating miRNAs: promising biomarkers of human cancer. Asian Pac J Cancer Prev. 2011;12(5):1117–1125.
   PubMed Web of Science ®Google Scholar
• Kleter B, van Doorn LJ, Ter Schegget J, Schrauwen L, van Krimpen K, Burger M, Ter Harmsel B, Quint W. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol. 1998;153(6):1731–1739. doi:10.1016/S0002-9440(10)65688-X.
   PubMed Web of Science ®Google Scholar
• Pao CC, Kao SM, Tang GC, Lee K, Si J, Ruan S. Prevalence of human papillomavirus DNA sequences in an area with very high incidence of cervical carcinoma. Br J Cancer. 1994;70(4):694–696. doi:10.1038/bjc.1994.375.
   PubMed Web of Science ®Google Scholar